What is BHRT and how do I know if I need it?

Short answer

• BHRT = bioidentical hormone replacement therapy: use of hormones that are molecularly identical to the hormones your body makes (estradiol, progesterone, testosterone) to treat hormone deficiency (most commonly menopausal symptoms).
• You might “need” it if you have significant symptoms (hot flashes/night sweats, vaginal dryness, sleep/mood problems, low libido, bone loss) that haven’t responded to lifestyle measures and you don’t have contraindications. A clinician will evaluate symptoms, run appropriate tests, review risks, and discuss benefits versus alternatives.

What BHRT is — in more detail

• Bioidentical hormones have the same chemical structure as human hormones. Examples: 17β‑estradiol and micronized progesterone.
• BHRT can be given as FDA‑approved products (patches, gels, pills, vaginal rings) or as compounded prescriptions (custom doses/creams/pellets made by compounding pharmacies). “Bioidentical” doesn’t automatically mean safer or more effective — the safety and quality depend on the product and prescribing/monitoring.

How it differs from standard HRT

• Standard HRT includes both FDA‑approved bioidentical molecules (like estradiol) and non‑bioidentical hormones (e.g., conjugated equine estrogens). Many FDA‑approved options are bioidentical.
• Compounded BHRT is less regulated and can have variable potency and purity; major medical organizations warn that compounded BHRT lacks the same safety and efficacy testing as FDA‑approved products.

Who might be a candidate

• Symptomatic menopausal women (moderate–severe hot flashes, night sweats, vaginal atrophy, sleep disruption, quality‑of‑life issues).
• People with premature ovarian insufficiency or surgical menopause.
• Men and women with clinically diagnosed low testosterone (men more commonly), under specialist supervision.

Who should NOT get BHRT (common contraindications)

• Current or past estrogen‑sensitive breast cancer (unless advised by an oncologist).
• Uncontrolled active liver disease, unexplained vaginal bleeding, recent stroke or heart attack, high risk of blood clots (history of VTE), pregnancy.
• These need individualized assessment.

How clinicians determine whether you need it

1. Symptom review and medical/family history (breast cancer, clots, cardiovascular disease).
2. Physical exam.
3. Baseline labs as indicated: serum estradiol, FSH/LH (for menopause), total testosterone (if symptoms of low T), SHBG, TSH, lipid panel, fasting glucose/HbA1c, and others as needed. Routine “saliva hormone tests” are not reliable for most decisions.
4. Bone density (DEXA) if osteoporosis risk.
5. Discuss risks/benefits and trial plan (often lowest effective dose, reassess in 3 months).

What the evidence and guidelines say

• FDA and major societies (North American Menopause Society, Endocrine Society) say some FDA‑approved bioidentical hormones are reasonable for symptomatic women, particularly if under 60 or within 10 years of menopause onset. There is no convincing evidence that compounded BHRT is safer than FDA‑approved HRT.
• Use the lowest effective dose for the shortest duration necessary for symptom control, and monitor.

Practical monitoring and follow‑up

• Reassess symptoms and side effects at ~3 months.
• Routine mammography and pelvic exams per age/risk.
• Periodic labs (lipids, metabolic panel); bone density as indicated.

Specific brands, tests and services to consider

• FDA‑approved estrogen options (bioidentical 17β‑estradiol): Estrace (oral estradiol), Vivelle‑Dot or Climara (transdermal patches), Estring or Femring (vaginal ring for local symptoms). These are manufactured and regulated, so dosing and purity are reliable.
• Progesterone: Prometrium (micronized progesterone) is an FDA‑approved, bioidentical oral option used for endometrial protection when uterus is present.
• Testosterone (men and sometimes prescribed off‑label for women with specialist care): AndroGel, Testim (for men). Testosterone for women is usually off‑label and should be managed by an experienced clinician.
• Labs: Use mainstream clinical labs such as LabCorp or Quest Diagnostics for reliable blood testing.
• If considering compounded BHRT: use a PCAB‑accredited compounding pharmacy (Pharmacy Compounding Accreditation Board) to reduce variability risk — but discuss pros/cons with your clinician first.
• Clinics and resources: consider a gynecologist or menopause specialist. Reputable centers: Mayo Clinic Menopause Clinic, Cleveland Clinic Center for Menopause (for second opinions or complex cases). North American Menopause Society (NAMS) website has patient guidance and lists specialists.

Next steps (quick checklist)

1. Track your symptoms for 2–4 weeks (frequency, severity, impact on life).
2. Schedule a visit with your primary care physician, gynecologist, or a menopause specialist.
3. Bring your symptom log and medical/family history.
4. If recommended, get baseline blood tests at LabCorp or Quest.
5. Discuss FDA‑approved options first; if considering compounded BHRT, ask about accreditation of the compounding pharmacy and close monitoring.
6. If started, plan follow‑up at ~3 months and regular preventive screening (mammogram, DEXA as indicated).

If you want, tell me:

• your age, symptoms, any medical history (especially breast cancer, clots, heart disease), and whether you’ve had labs done — I can suggest what to discuss with a clinician and which specific tests to request.